UBS analyst Thomas Wadewitz raised the firm’s price target on ArcBest (ARCB) to $84 from $64 and keeps a Neutral rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB:
- ArcBest price target raised to $89 from $75 at JPMorgan
- ArcBest’s Mixed Financial Outlook: Hold Rating Amidst Improved Tonnage and Weak Market Conditions
- ArcBest Amends Receivables Loan Agreement for 2025
- ArcBest price target raised to $85 from $75 at Jefferies
- McDonald’s downgraded on GLP-1 drug worries: Wall Street’s top analyst calls